Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Blood thinner timing after polyp removal: sooner may be safe

NCT ID NCT06482333

First seen May 10, 2026

Summary

This study looks at whether restarting blood thinners (DOACs) right after colonoscopy polyp removal is as safe as waiting two days. About 194 adults on DOACs who need a colonoscopy will be randomly assigned to restart their medication on the same day or two days later. The goal is to compare bleeding and clot risks between the two groups.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPOLYPECTOMY BLEEDING are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Queen Mary Hospital, the University of Hong Kong

    RECRUITING

    Hong Kong, Hong Kong

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Direct Oral Anticoagulants (DOACs)

What this could lead to

If early resumption is safe, patients on blood thinners may be able to restart their medication sooner after polyp removal, reducing their risk of blood clots.

What could go wrong

This is a small, early-phase trial (194 participants) testing timing only, not a new treatment. The results may not apply to all patients or procedures.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.